Lagos, Nigeria - 08 November 2023 – MeCure Industries Plc (“MeCure Industries” or the “Company”) is pleased to announce the successful listing of its shares on the Growth Board of The Nigerian Exchange Limited (“NGX” or “The Exchange”). MeCure Industries is a pharmaceutical company with a track record of enhancing service and product delivery across the pharmaceutical and healthcare industry value chain.
MeCure Industries has satisfied the listing requirements of the Nigerian Exchange Limited and obtained all relevant regulatory approvals. We are now listed in the pharmaceutical sector of the Exchange, with the ticker “MECURE”. A total of 4,000,000,000 (Four Billion) ordinary shares were admitted to trading, representing the total issued share capital of the Company, with one of the largest market capitalisation on the Standard Segment of the NGX’s Growth Board.
Commenting on the listing, the Chairman and Founder, Mr Samir Udani said "The approval to list on the Growth Board of the Nigerian Exchange Limited marks a significant milestone in the journey to achieving our strategic expansion goals and healthy contribution to the national economy through continued reduction of the nation's dependency on import as the primary medium of access to pharmaceutical products."
“By listing on the Nigerian Exchange Limited, we will gain more visibility and expand our reach, thus attracting new investors and strengthening relationships with existing ones," said Mrs Anderline Dukor, Co-CEO of MeCure. "In addition to delivering value to shareholders, we are excited about the opportunities ahead."
Mr Arjun Udani, Co-CEO of MeCure Industries, also added, "The listing marks a new beginning for us as a Company; as it resonates with our commitment to saving lives through innovation and enhancing the health of our consumers by delivering high-quality products, while we maintain sustainable growth of the Company”.
Ifedamola Oluwasegun
Chief Financial officer
Værdi Investor Relations
Oluyemisi Lanre-Phillips
About MeCure Industries Plc
MeCure Industries is a company principally in the business of manufacturing drugs in Nigeria under two categories namely pharmaceuticals and nutraceuticals. In the pursuit of its primary objective, it adopts the use of modern-day technology and expertise care in services to restore health and save lives through its diverse solutions.
For over a decade, MeCure has developed a reputation for quality and is trusted by its stakeholders (customers, distributors, suppliers, shareholders, employees, etc.). Growth has been demonstrated through historical revenue and market share growth, backed by an experienced management team with over 150 years’ experience across multiple disciplines with a deep understanding of the pharmaceutical industry.
